Kayentis Overview

  • Founded
  • 2003
Founded
  • Status
  • Private
  • Employees
  • 152
Employees
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $8.3M
Latest Deal Amount
  • Investors
  • 7

Kayentis General Information

Description

Developer of electronic clinical outcome assessment (eCOA) technology designed to offer new perspectives to speed up clinical trials. The company's technology backs in electronic data capture for patients in clinical trials and offers a wide range of tools that are used together and adaptable for all clinical study needs, enabling sponsors and clinical trial operators to bring simplicity to the collection of clinical trials data for both patients and sites.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Medical Records Systems
Other Industries
Other Healthcare Technology Systems
Primary Office
  • 19 bis
  • Chemin du vieux Chêne
  • 38240 Meylan
  • France
+33 04 00 00 00 00

Kayentis Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Kayentis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC 02-Dec-2020 $8.3M 000.00 000.00 Completed Generating Revenue
7. Secondary Transaction - Private 000.00 Completed Generating Revenue
6. Later Stage VC 21-Mar-2019 00.000 000.00 000.00 Completed Generating Revenue
5. Later Stage VC 17-Oct-2016 00.00 000.00 Completed Generating Revenue
4. Later Stage VC 25-Feb-2015 00.00 000.00 Completed Generating Revenue
3. Later Stage VC (Series C) 10-May-2011 00.000 000.00 Completed Generating Revenue
2. Later Stage VC (Series C) 01-Sep-2007 $6.2M $8.6M Completed Startup
1. Early Stage VC (Series A) 01-Dec-2005 $2.4M $2.4M Completed Startup
To view Kayentis’s complete valuation and funding history, request access »

Kayentis Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
P shares 0,000,000 00.000000 00.00 00.00 00 00.00 0.000
To view Kayentis’s complete cap table history, request access »

Kayentis Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of electronic clinical outcome assessment (eCOA) technology designed to offer new perspectives to speed up cli
Medical Records Systems
Meylan, France
152 As of 2021
000.00
00.00 0000-00-00
0000000000 0 000.00

000000

te irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Exce
00000 0000000000 0000000000 0000000
Malvern, PA
00 As of 0000
000.00
000000000 -

00000000

met, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
00000 0000000000 0000000000 0000000
Philadelphia, PA
0000 As of 0000
00000
0000000 0000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Kayentis Competitors (13)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
YPrime Private Equity-Backed Malvern, PA 00 000.00 000000000 -
000000000 00000000 Private Equity-Backed Philadelphia, PA 0000 00000 0000000 0000 00000
0000000 Venture Capital-Backed San Jose, CA 00 00.00 000000000 00.00
000000 Venture Capital-Backed Amsterdam, Netherlands 000 000.00 00000000000 000.00
000000 Venture Capital-Backed New York, NY 000 00000 00000000000 00000
You’re viewing 5 of 13 competitors. Get the full list »

Kayentis Executive Team (9)

Name Title Board Seat Contact Info
Guillaume Juge President and Chief Executive Officer
Laurence Fayand Chief Financial Officer
Estelle Bonelli Chief Operating Officer
Frederique Marion Business Development Director
Philippe Berna Founder & Owner
You’re viewing 5 of 9 executive team members. Get the full list »

Kayentis Board Members (6)

Name Representing Role Since
Arnaud Houette Extens Board Member 000 0000
Cedric Berger Self Board Member 000 0000
Chantal Parpex MD Innovation Capital (Paris) Board Member 000 0000
Franck Noiret Innovation Capital Board Member 000 0000
Jean-Luc Lenart Kayentis Chairman 000 0000
You’re viewing 5 of 6 board members. Get the full list »

Kayentis Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Kayentis Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Bpifrance Sovereign Wealth Fund Minority 000 0000 000000 0
Innovation Capital (Paris) Venture Capital Minority 000 0000 000000 0
KCE Consultants Other Minority 000 0000 000000 0
LBO France PE/Buyout Minority 000 0000 000000 0
Lenapart Other Minority 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »